相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Estimates of the Prevalence and Incidence of Chlamydia and Gonorrhea Among US Men and Women, 2018
Kristen M. Kreisel et al.
SEXUALLY TRANSMITTED DISEASES (2021)
Effect of screening young men for Chlamydia trachomatis on the rates among women: a network modelling study for high-prevalence communities
Zhuolin Qu et al.
BMJ OPEN (2021)
Assessing the costs and outcomes of control programmes for sexually transmitted infections: a systematic review of economic evaluations
Sonja C. M. Bloch et al.
SEXUALLY TRANSMITTED INFECTIONS (2021)
Improving Women's Health and Combatting Sexually Transmitted Infections Through Expedited Partner Therapy
Cornelius D. Jamison et al.
OBSTETRICS AND GYNECOLOGY (2019)
The Impact of Screening and Partner Notification on Chlamydia Prevalence and Numbers of Infections Averted in the United States, 2000-2015: Evaluation of Epidemiologic Trends Using a Pair-Formation Transmission Model
Minttu M. Ronn et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2019)
Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015
Elizabeth A. Van Dyne et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Recurrent respiratory papillomatosis: A state-of-the-art review
Helena Ribeiro Fortes et al.
RESPIRATORY MEDICINE (2017)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Uptake and Population-Level Impact of Expedited Partner Therapy (EPT) on Chlamydia trachomatis and Neisseria gonorrhoeae: The Washington State Community-Level Randomized Trial of EPT
Matthew R. Golden et al.
PLOS MEDICINE (2015)
Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Predictors of Index Patient Acceptance of Expedited Partner Therapy for Chlamydia trachomatis Infection and Reasons for Refusal, Sexually Transmitted Disease Clinics, New York City, 2011 to 2012
Sheila Vaidya et al.
SEXUALLY TRANSMITTED DISEASES (2014)
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
Catherine Lindsey Satterwhite et al.
SEXUALLY TRANSMITTED DISEASES (2013)
Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States
Harrell W. Chesson et al.
VACCINE (2012)
The Cost and Cost-Effectiveness of Expedited Partner Therapy Compared With Standard Partner Referral for the Treatment of Chlamydia or Gonorrhea
Thomas L. Gift et al.
SEXUALLY TRANSMITTED DISEASES (2011)
Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study
Katy Turner et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men
J. Hislop et al.
HEALTH TECHNOLOGY ASSESSMENT (2010)
Incidence and Costs of Cervical Intraepithelial Neoplasia in a US Commercially Insured Population
Henry J. Henk et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2010)
Surveillance After Treatment for Cervical Intraepithelial Neoplasia Outcomes, Costs, and Cost-Effectiveness
Joy Melnikow et al.
OBSTETRICS AND GYNECOLOGY (2010)
The economic burden of noncervical human papillomavirus disease in the United States
Delphine Hu et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Health and economic implications of HPV vaccination in the United States
Jane J. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The Program Cost and Cost-Effectiveness of Screening Men for Chlamydia to Prevent Pelvic Inflammatory Disease in Women
Thomas L. Gift et al.
SEXUALLY TRANSMITTED DISEASES (2008)
The direct medical cost of epididymitis and orchitis: Evidence from a study of insurance claims
Thomas L. Gift et al.
SEXUALLY TRANSMITTED DISEASES (2006)
Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more
SJ Goldie et al.
OBSTETRICS AND GYNECOLOGY (2004)
Diagnoses and outcomes in cervical cancer screening: A population-based study
RP Insinga et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
The economic cost of squamous cell cancer of the head and neck - Findings from linked SEER-Medicare data
K Lang et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2004)
The estimated direct medical cost of sexually transmitted diseases among American youth, 2000
HW Chesson et al.
PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH (2004)
The health and economic burden of genital warts in a set of private health plans in the United States
RP Insinga et al.
CLINICAL INFECTIOUS DISEASES (2003)
Cost effectiveness of screening for Chlamydia trachomatis:: a review of published studies
E Honey et al.
SEXUALLY TRANSMITTED INFECTIONS (2002)
Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle
LR Armstrong et al.
CLINICAL INFECTIOUS DISEASES (2000)
Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men
SJ Goldie et al.
AMERICAN JOURNAL OF MEDICINE (2000)
分享论文
